Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Teva Pharmaceutical Industries Ltd (TEVA)

11.08   -0.24 (-2.12%) 02-25 11:29
Open: 11.19 Pre. Close: 11.32
High: 11.3 Low: 10.94
Volume: 3,700,081 Market Cap: 11,812M
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, the company provides specialty medicines for use in central nervous system and respiratory indications. Further, its products in the central nervous system and pain area comprise Copaxone for the treatment of relapsing forms of MS; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. Additionally, the company's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Braltus, Cinqair/Cinqaero, and AirDuo RespiClick/ArmonAir RespiClick/AirDuo Digihaler for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. It has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.486 - 11.551 11.551 - 11.61
Low: 10.37 - 10.449 10.449 - 10.522
Close: 11.198 - 11.32 11.32 - 11.432

Technical analysis

as of: 2021-02-25 11:17:40 AM
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 14.24     One year: 15.53
Support: Support1: 10.39    Support2: 8.64
Resistance: Resistance1: 12.19    Resistance2: 13.30
Pivot: 11.53
Moving Average: MA(5): 10.97     MA(20): 11.68
MA(100): 10.36     MA(250): 10.50
MACD: MACD(12,26): -0.16     Signal(9): -0.01
Stochastic oscillator: %K(14,3): 20.50     %D(3): 12.94
RSI: RSI(14): 44.81
52-week: High: 13.30  Low: 6.25  Change(%): -4.3
Average Vol(K): 3-Month: 959785  10-Days: 1082416

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
TEVA has closed above bottom band by 31.6%. Bollinger Bands are 65.9% wider than normal. The large width of the bands suggest high volatility as compared to TEVA's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Thu, 25 Feb 2021
April 9th Options Now Available For Teva Pharmaceutical Industries (TEVA) - Nasdaq

Thu, 25 Feb 2021
Celiac Disease Market Is Touching New Level – A Comprehensive Study With Key PlayersInnovate Biopharmaceuticals,Teva Pharmaceutical Industries Ltd,ImmunogenX, LLC,Amgen,ChemoCentryx, Inc,Anokion SA,COUR Pharmaceutical – KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper

Tue, 23 Feb 2021
Generic-Drug Labeling Strategy Likely to Survive Teva Rehearing - Bloomberg

Tue, 23 Feb 2021
Teva Pharmaceutical Industries (TEVA) Shares Cross Below 200 DMA - Nasdaq

Thu, 11 Feb 2021
April 1st Options Now Available For Teva Pharmaceutical Industries - Nasdaq

Thu, 11 Feb 2021
The Teva Pharmaceutical Industries Limited (NYSE:TEVA) Yearly Results Are Out And Analysts Have Published New Forecasts - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 1,100
Shares Float (M) 1,090
% Held by Insiders 1.02
% Held by Institutions 51.78
Shares Short (K) 29,750
Shares Short P. Month (K) 32,660

Stock Financials

EPS -3.680
EPS Est This Year 4.230
EPS Est Next Year 3.690
Book Value (p.s.) 8.750
Profit Margin -24.18
Operating Margin 18.19
Return on Assets (ttm) 3.5
Return on Equity (ttm) -32.8
Qtrly Rev. Growth -2.8
Gross Profit (p.s.) 6.855
Sales Per Share 15.155
EBITDA (p.s.) 4.191
Qtrly Earnings Growth
Operating Cash Flow (M) 1,420
Levered Free Cash Flow (M) 2,590

Stock Valuations

PE Ratio -3.00
PEG Ratio
Price to Book value 1.26
Price to Sales 0.73
Price to Cash Flow 8.54

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date 2017-12-11
Ex-Dividend Date 2017-11-26
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.